What does Dr. Bloemen Eline huisarts do?

Dr. Bloemen Eline huisarts is a general practice in Leuven. Private Limited, started on 25 September 2018, 1 establishment.

What is the address of Dr. Bloemen Eline huisarts?

The registered office of Dr. Bloemen Eline huisarts is located at Hortense Damanhof 4, 3001 Leuven.

Is Dr. Bloemen Eline huisarts still active?

Yes. According to the CBE (2 October 2026) Dr. Bloemen Eline huisarts is active, legal situation “Normale toestand”, started on 25 September 2018.

Is Dr. Bloemen Eline huisarts registered on Peppol?

Yes, Dr. Bloemen Eline huisarts is registered on the Peppol network with ID 0208:0705822676.

What is the enterprise number of Dr. Bloemen Eline huisarts?

The enterprise number of Dr. Bloemen Eline huisarts is BE0705822676.

When was Dr. Bloemen Eline huisarts founded?

Dr. Bloemen Eline huisarts was founded on 25 September 2018.

Who are the directors of Dr. Bloemen Eline huisarts?

According to the 2025 annual accounts, the directors of Dr. Bloemen Eline huisarts are: Eline Louise Bloemen.

Is Dr. Bloemen Eline huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 September 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Bloemen Eline huisarts make in 2025?

Dr. Bloemen Eline huisarts posted a profit after taxes of € 61,996 in financial year 2025.

What is the revenue of Dr. Bloemen Eline huisarts?

As a small company, Dr. Bloemen Eline huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 82,471.

Dr. Bloemen Eline huisarts (Private Limited) - Leuven

Dossier Dr. Bloemen Eline huisarts, printed on 2 October 2026 from databakkes.be/en/0705822676/dr-bloemen-eline-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 52 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Dr. Bloemen Eline huisarts from Leuven, company number BE0705822676, closed financial year 2025 with a result of € 61,996 after tax. For that financial year Dr. Bloemen Eline huisarts recorded a gross margin of € 82,471 and equity of € 18,601. Compared with financial year 2024, the result moved from € 70,827 to € 61,996. The company is profitable. The buffer shrank hard: equity is 78 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.

What it is worth Shrank hard

€ 18,601

▼ 78% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 61,996

▼ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 52,802

▼ 45% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 128,200 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,205

▲ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 39,996 Gross margin 2022: € 39,996 First fiscal year in the series	€ 62,710 Gross margin 2023: € 62,710 ▲ 57% vs 2022 (€ 39,996) Favourable step	€ 94,004 Gross margin 2024: € 94,004 ▲ 50% vs 2023 (€ 62,710) Favourable step	€ 82,471 Gross margin 2025: € 82,471 ▼ 12% vs 2024 (€ 94,004) Unfavourable step	▼ 12%
Profit after taxes	€ 28,758 Profit after taxes 2022: € 28,758 First fiscal year in the series	€ 46,112 Profit after taxes 2023: € 46,112 ▲ 60% vs 2022 (€ 28,758) Favourable step	€ 70,827 Profit after taxes 2024: € 70,827 ▲ 54% vs 2023 (€ 46,112) Favourable step	€ 61,996 Profit after taxes 2025: € 61,996 ▼ 12% vs 2024 (€ 70,827) Unfavourable step	▼ 12%
Equity	€ 87,866 Equity 2022: € 87,866 First fiscal year in the series	€ 83,978 Equity 2023: € 83,978 ▼ 4% vs 2022 (€ 87,866) Unfavourable step	€ 84,805 Equity 2024: € 84,805 ▲ 1% vs 2023 (€ 83,978) Favourable step	€ 18,601 Equity 2025: € 18,601 ▼ 78% vs 2024 (€ 84,805) Unfavourable step	▼ 78%
Total debts	€ 101,741 Total debts 2022: € 101,741 First fiscal year in the series	€ 55,987 Total debts 2023: € 55,987 ▼ 45% vs 2022 (€ 101,741) Favourable step	€ 74,790 Total debts 2024: € 74,790 ▲ 34% vs 2023 (€ 55,987) Unfavourable step	€ 104,613 Total debts 2025: € 104,613 ▲ 40% vs 2024 (€ 74,790) Unfavourable step	▲ 40%
Cash	€ 146,485 Cash 2022: € 146,485 First fiscal year in the series	€ 99,814 Cash 2023: € 99,814 ▼ 32% vs 2022 (€ 146,485) Unfavourable step	€ 95,359 Cash 2024: € 95,359 ▼ 4% vs 2023 (€ 99,814) Unfavourable step	€ 52,802 Cash 2025: € 52,802 ▼ 45% vs 2024 (€ 95,359) Unfavourable step	▼ 45%
Retained profit	€ 69,266 Retained profit 2022: € 69,266 First fiscal year in the series	€ 65,378 Retained profit 2023: € 65,378 ▼ 6% vs 2022 (€ 69,266) Unfavourable step	€ 66,205 Retained profit 2024: € 66,205 ▲ 1% vs 2023 (€ 65,378) Favourable step	€ 1 Retained profit 2025: € 1 ▼ € 66,204 vs 2024 (€ 66,205) Unfavourable step	▼ € 66,204
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 50,000 Dividend 2023: € 50,000 ▼ 50% vs 2022 (€ 100,000) Unchanged	€ 70,000 Dividend 2024: € 70,000 ▲ 40% vs 2023 (€ 50,000) Unchanged	€ 128,200 Dividend 2025: € 128,200 ▲ 83% vs 2024 (€ 70,000) Unchanged	▲ 83%
Balance sheet total	€ 189,607 Balance sheet total 2022: € 189,607 First fiscal year in the series	€ 139,964 Balance sheet total 2023: € 139,964 ▼ 26% vs 2022 (€ 189,607) Unchanged	€ 159,595 Balance sheet total 2024: € 159,595 ▲ 14% vs 2023 (€ 139,964) Unchanged	€ 123,214 Balance sheet total 2025: € 123,214 ▼ 23% vs 2024 (€ 159,595) Unchanged	▼ 23%

Key figures of Dr. Bloemen Eline huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Bloemen Eline huisarts?

What happened at Dr. Bloemen Eline huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 30, 2026 New annual accounts for financial year 2025: profit of € 61,996 (▼ 12% vs 2024). Source: NBB ↗
2023 Eline Louise Bloemen became a director. NBB
Sep 25, 2018 New establishment in Bertem. KBO
Sep 25, 2018 Start of the company according to the CBE. KBO

In short

From € 28,758 profit in 2022 to € 61,996 profit in 2025.

Paid € 55,299 in corporate taxes since 2022.

Best year ever: 2024, with € 70,827 profit.

Paid out € 348,200 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Bloemen Eline huisarts? We notify you, reason included.

Follow Dr. Bloemen Eline huisarts

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Eline Louise Bloemen

Dr. Bloemen Eline huisarts

Huisartsenpraktijk Het Dorp

Behind Dr. Bloemen Eline huisarts is Eline Louise Bloemen. Eline Louise Bloemen is also behind Huisartsenpraktijk Het Dorp.

See the full network in the app

Directors

According to the 2025 annual accounts

Eline Louise Bloemen

Director

Also active at: Huisartsenpraktijk Het Dorp

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Hortense Damanhof 4

3001 Leuven

2.280.277.186

Van Hoofstraat 10

3061 Bertem

Active since 25 September 2018

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0705.822.676
VAT number: BE 0705.822.676
Registered office: Hortense Damanhof 4, 3001 Leuven
Names & denominations: Dr. Bloemen Eline huisarts
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 25 September 2018
Peppol: Active · Active since 2 Dec 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗